ADPT- Adaptive Biotechnologies Corporation

Name: Adaptive Biotechnologies Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robins Chad M	2.18M	$51.46M	-
Other	Bobulsky Susan	401.3K	$9.47M	-5,000
CFO	Piskel Kyle	256.7K	$6.06M	-
Other	Lo Francis	230.7K	$5.44M	-105,762
Other	Benzeno Sharon	113.5K	$2.68M	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 4, 2025	Benzeno Sharon78	Chief Commercial Ofc Imm Med	Sale+OE	12,604	$16.85	$212,377.40	-4.1%	-5.8%	-
Dec 4, 2025	Robins Harlan S83	Chief Scientific Officer	Sell	37,212	$18.07	$672,515.32	-1.5%	-5.8%	-
Dec 1, 2025	Robins Chad M62	CEO And Chairman	Sell	160,734	$19.10	$3,070,746.60	-2.8%	-14.5%	-
Nov 28, 2025	Piskel Kyle	Chief Financial Officer	Sale+OE	162,820	$19.50	$3,174,990.00	-42.9%	-16.3%	-
Nov 21, 2025	Benzeno Sharon78	Chief Commercial Ofc Imm Med	Sale+OE	606,402	$16.73	$10,144,025.57	-50.5%	-13.8%	-
Nov 17, 2025	Piskel Kyle	Chief Financial Officer	Sell	238	$14.05	$3,343.90	-	+15.2%	-
Nov 12, 2025	Robins Chad M62	CEO And Chairman	Sell	89,265	$14.73	$1,315,179.62	-1.0%	+7.9%	-
Nov 10, 2025	Robins Harlan S83	Chief Scientific Officer	Sell	10,000	$14.82	$148,200.00	-0.8%	+7.8%	-
May 16, 2025	Piskel Kyle	Chief Financial Officer	Sell	1,929	$8.89	$17,148.81	-0.7%	+42.8%	+41.8%
May 1, 2025	Robins Harlan S83	Chief Scientific Officer	Sale+OE	68,412	$7.35	$502,828.20	-5.1%	+41.8%	+93.9%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC